Results 271 to 280 of about 1,436,444 (347)

The lymphocyte function of allogeneic peripheral blood stem cell grafts is associated with relapse and cytomegalovirus reactivation

Transfusion, EarlyView.
Abstract Background Allogeneic hematopoietic stem cell transplantation (HSCT) is a treatment primarily for hematological malignancies. Infections, relapse, and graft versus host disease (GvHD) are some of the most common adverse events following HSCT. We aimed to evaluate whether the lymphocyte function of the stem cell graft was associated with these ...
Anna Söderström, Tengyu Wang, Johan Törlén, Hannes Lindahl, Davide Valentini, Stephan Mielke, Klara Asplund Högelin, Rebecca Axelsson Robertson, Michael Uhlin   +8 more
wiley   +1 more source

Engineering CAR-T cells for solid tumors: overcoming antigenic, trafficking, and microenvironmental barriers. [PDF]

Front Immunol
Kong Z, Wang J.
europepmc   +1 more source

Progress of Myeloid-Associated Antigens Such as CD7 and CD19 in AML

Advances in Clinical Medicine
openaire   +1 more source

Clinical Implications of CD19-Negative Relapse Following CD19-Directed Therapy in B-Cell Acute Lymphoblastic Leukemia. [PDF]

Am J Hematol
Othman T, Agrawal V, Song JY, Gu Z, Koller P, Pourhassan H, Samara Y, Thiebaud JA, Tinajero J, Ngo D, Lin R, Sandhu K, AlMalki M, Aribi A, Otoukesh S, Ball B, Artz A, Salhotra A, Khaled S, Blackmon A, Amanam I, Ali H, Park S, Becker P, Nakamura R, Marcucci G, Stein A, Forman S, Pullarkat V, Aldoss I.   +29 more
europepmc   +1 more source

BCMA Antigen Loss Through Acquired TNFRSF17 Deletion in Multiple Myeloma

International Journal of Laboratory Hematology, EarlyView.
Ali Benaboud, Rémi Tilmont, Gauthier Decool, Nicolas Gower, Salomon Manier, Benjamin Podvin   +5 more
wiley   +1 more source

Exploring current evidence on bispecific CAR-T cell therapy for acute leukemias: a systematic review. [PDF]

Front Oncol
Husodho GVP, Kumalasari ADA, Faiza AH, Limijadi EKS, Hendrianingtyas M.   +4 more
europepmc   +1 more source

Next-generation T cell engagers for cancer and autoimmune diseases. [PDF]

Front Immunol
Michaelson JS, Henry CC, Sauer K, Baeuerle PA.   +3 more
europepmc   +1 more source

An Overview on T-Cell Engagers: The Current Position in Both the Biological and Mathematical Context. [PDF]

Comput Struct Biotechnol J
Davies J, Brown LV, Jones MW, Penney M, Powathil G.   +4 more
europepmc   +1 more source

Emerging Applications of CAR-T Cell Therapy in Overcoming Resistance and Expanding Targets in Hematologic Malignancies: Insights from Recent Research. [PDF]

Curr Treat Options Oncol
Alipourfard I, Shafaghat Z, Saharkhiz S, Farani MR, Bakhtiyari S.   +4 more
europepmc   +1 more source

Current advances in 2025: A critical review of selected topics by the Association for the Advancement of Blood and Biotherapies (AABB) Clinical Transfusion Medicine Committee

Transfusion, EarlyView.
Nabiha H. Saifee, Jennifer Andrews, Mary Berg, Stella T. Chou, Mischa Covington, Elizabeth P. Crowe, Ruchika Goel, Juliana A. Guarente, Tina Ipe, Jeremy W. Jacobs, Jessica Jacobson, Cyril Jacquot, Jenna Khan, Thane A. Kubik, Theodros Mamo, Michael F. Murphy, Kerry O'Brien, Monica B. Pagano, Anil K. Panigrahi, Jacqueline N. Poston, Scott E. Potter, Simon J. Stanworth, Moritz Stolla, Alyssa Ziman, Ryan A. Metcalf   +24 more
wiley   +1 more source